Riskpilot← Back to searchSign inGet full accessR. MARIUS BARSTAD AS
ASActiveOrg 990875189Bergheimveien 18, 1367 SnarøyaMedical specialists activities · NACE 8622Est. 20072 employees
Revenue 2024
NOK 2,1M
-22% vs 2023
EBITDA margin
18.1%
-59% vs 2023
Equity ratio
77.3%
Financial strength
Net profit 2024
NOK 3M
+40% vs 2023
| Revenue | NOK 2,1M | -22% |
| EBITDA | NOK 377K | -59% |
| Net profit | NOK 3M | +40% |
| Total assets | NOK 12,1M | +7% |
| Equity | NOK 9,4M | +8% |
| Employees | 2 | — |
Legal name
R. MARIUS BARSTAD AS
Org number
990875189
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. februar 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Medisinsk virksomhet og utvikling, investeringer i verdipapirer og eiendom.
Address
Bergheimveien 18, 1367 Snarøya
Phone
+4791160054
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 482 | 2 685 | 3 160 | 2 659 | 2 080 |
| Staff expenses | −1 624 | −1 614 | −1 401 | −1 417 | −1 407 |
| EBITDA | 1 451 | 708 | 1 151 | 917 | 377 |
| Depreciation & amort. | −342 | −361 | −236 | −233 | −233 |
| EBIT | 1 109 | 347 | 915 | 683 | 143 |
| Net financials | 1 737 | 1 283 | −438 | 1 643 | 2 952 |
| Profit before tax | 2 847 | 1 630 | 477 | 2 327 | 3 095 |
| Tax | 275 | 98 | 749 | 164 | 74 |
| Net profit | 2 572 | 1 531 | −272 | 2 162 | 3 021 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 066 | 15 693 | 21 000 | 11 315 | 12 115 |
| Equity | 10 323 | 10 854 | 9 582 | 8 644 | 9 365 |
| Long-term debt | 2 954 | 3 002 | 1 398 | 680 | 576 |
| Short-term debt | 1 789 | 1 837 | 10 021 | 1 991 | 2 174 |
| Total debt | 4 743 | 4 839 | 11 418 | 2 671 | 2 750 |
EBITDA margin
18.1%
This company
15.8%
Market median
+15% vs market
20202024
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
32.3%
This company
18.4%
Market median
+76% vs market
20202024
Net profit margin
145.3%
This company
8.1%
Market median
+1694% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BE Deputy Member | Deputy Member | 2007 |
RM Chief Executive Officer | Chief Executive Officer | 2007 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
R. MARIUS BARSTAD AS 
Fornebuklinikken AsBoard members of R. MARIUS BARSTAD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bente Eger | Deputy Member | 0 companies |
| Rolf Marius Barstad | Chief Executive Officer | 0 companies |